KANTARO BIOSCIENCES
Dead / Abandoned — Abandoned — failure to respond (as of 17 Jun 2021)
What this means for you
This application is over — abandoned 11 May 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88922058
- Mark type
- Stylized text
- Filed
- 18 May 2020
- Abandoned
- 11 May 2021
- Attorney of record
- Michelle A. Cooke
Goods and services
- Class 005 — Pharmaceuticals: Medical preparations; Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, media, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Kits and components for use in diagnostic testing; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical test kits for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring; Diagnostic preparations for medical purposes for detecting the presence of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Preparations and substances for the diagnosis, prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders
Owner
- Kantaro Biosciences LLC, New York, NY, US
Prosecution history
- 17 Jun 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 17 Jun 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 08 Nov 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Nov 2020 — NON-FINAL ACTION E-MAILED
- 08 Nov 2020 — NON-FINAL ACTION WRITTEN
- 08 Nov 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Nov 2020 — NON-FINAL ACTION E-MAILED
- 08 Nov 2020 — NON-FINAL ACTION WRITTEN
- 07 Nov 2020 — ASSIGNED TO EXAMINER
- 03 Jun 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 May 2020 — NEW APPLICATION ENTERED